The Singapore Court of Appeal Rules on Post Grant Amendments to Patents and Validity of Second Medical Use Claims
On 1 August 2017, the Singapore Court of Appeal in Warner-Lambert Company LLC v Novartis (Singapore) Pte Ltd [2017] SGCA 45 dismissed Warner-Lambert’s application to amend its patent for the use of pregabalin for the treatment of pain (the “Patent”).